๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Sertraline in the treatment of anxiety disorders

โœ Scribed by Robert M.A. Hirschfeld

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
227 KB
Volume
11
Category
Article
ISSN
1091-4269

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Efficacy of ondansetron in the treatment
Efficacy of ondansetron in the treatment of generalized anxiety disorder
โœ A. M. Freeman III; J. R. Westphal; G. T. Norris; B. A. Roggero; P. B. Webb; K. L ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 42 KB ๐Ÿ‘ 1 views

Ondansetron is a highly selective antagonist at the 5-HT 3 subtype of serotonin (5-HT) receptors . The 5-HT 3 receptors are the only receptors whose effects are mediated through the ion channels rather than the G-protein series . Ondansetron has no appreciable affinity for other 5-HT receptor subtyp

Therapeutic advances: Paroxetine for the
Therapeutic advances: Paroxetine for the treatment of social anxiety disorder
โœ R. Bruce Lydiard; Julio Bobes ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 99 KB ๐Ÿ‘ 1 views

## Data from early studies of selective serotonin reuptake inhibitors have shown that these agents are effective in the treatment of social anxiety disorder (social phobia). This review highlights the outcomes of three large clinical trials of paroxetine in patients with social anxiety disorder. In